HenockSaint-JacquesMD
Cardiology • New York, NYEchocardiography, Nuclear Cardiology, Vascular Medicine
President & Medical Director
Dr. Saint-Jacques is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1787 Madison Ave
Ste 50C
New York, NY 10035Phone+1 212-348-9400Fax+1 212-348-9405
Education & Training
Duke University HospitalPost-Doctoral Fellowship, 2001 - 2003- Duke University HospitalFellowship, Cardiovascular Disease, 2000 - 2003
Montreal Heart InstituteFellowship, Cardiology, 1998 - 2001
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1995 - 1998
Universidad de Ciencias MedicasClass of 1993
Certifications & Licensure
NY State Medical License 2000 - 2025
NC State Medical License 1999 - 2004- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Preceptor Of The Year Touro College of Osteopathic Medicine, New York, NY, 2016
- Meaningful Use stage 3 certification Centers for Medicare & Medicaid Services, 2013
- Meaningful Use stage 2 certification Center for Medicare & Medicaid Services, 2012
- Join now to see all
Clinical Trials
- EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED) Start of enrollment: 2004 Nov 01
- IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103) Start of enrollment: 2005 Oct 17
- A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure Start of enrollment: 2006 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsDiabetes, Heart Failure and Beyond: Elucidating the Cardioprotective Mechanisms of Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors.Utkarsh Ojha, Lenisse Reyes, Florence Eyenga, Diane Oumbe, Justyna Watkowska
American Journal of Cardiovascular Drugs. 2021-06-30 - 1 citationsExercise-Induced Sustained Ventricular Tachycardia without Structural Heart Disease: A Case Report.Michelle Audrey Darmadi, Axel Duval, Hanaa Khadraoui, Alberto N Romero, Blanca Simon
The American Journal of Case Reports. 2020-12-10 - 18 citationsEffect of the novel direct factor Xa inhibitor DX-9065a on thrombin generation and inhibition among patients with stable atherosclerotic coronary artery diseaseRichard C. Becker, John H. Alexander, Christopher K. Dyke, Yao Huang, Henock Saint-Jacques
Thrombosis Research. 2006-01-01
Abstracts/Posters
- PREDICTORS OF MAJOR HEMORRGAGE FOLLOWING INITIATION OF WARFARIN THERAPYSAINT-JACQUES, HENOCK, ACC 2004, NEW ORLEANS
- Demographic and Predictors of excessive anticoagulation following initiation of warfarin therapySaint-Jacques, Henock MD;, American College of Cardiology Annual Scientific Sessions, Chicago, IL, 3/2003
Professional Memberships
- Member
- Fellow
- Member
- Member
- Member
- Association of Black Cardiologists, Inc.Member
Other Languages
- Spanish, French, Creole
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
